product
DiscoverX GPCRscan® GPCR Profiling Services
22 February 2016 | By DiscoverX Corporation
GPCRscan is a functional cell-based GPCR assay panel for profiling drug compounds during drug discovery...
List view / Grid view
Screening
Medical screening is a strategy used to identify the possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms.
product
DiscoverX BioMAP® Diversity PLUS Panel
19 February 2016 | By DiscoverX Corporation
Diversity PLUS Panel contains 12 human primary cell systems from multiple tissues that model human disease for predictive insight into drug efficacy and MOA...
product
DiscoverX PathHunter® Checkpoint Signaling Assays
19 February 2016 | By DiscoverX Corporation
PathHunter® Checkpoint Assays enable screening and potency assays for the development of immunotherapy drugs...
whitepaper
Handbook: An introduction to Antibodies and their applications, 3rd ed
A concise overview of some of the key features for the use of antibodies and immunochemical techniques in biological research...
article
The relevance of homogeneous radiometric assays in modern drug discovery
In the past two decades, several alternative, non-radiometric assay formats have been developed for the high-throughput screening (HTS) of target classes such as protein kinases, which were previously screened using radiometric assays. Radiometric screening (and the expertise to perform such HTS) has thus declined in recent years...
article
Finding a cure for neglected tropical diseases with cell-based assays
Neglected tropical diseases pose a significant threat to public health and affect nearly one billion people in tropical and sub-tropical regions throughout the world. There is a pressing need to identify new therapeutics for NTDs and many developed nations are participating in drug discovery efforts...
product
DiscoverX BioMAP® Phenotypic Profiling Services
12 February 2016 | By DiscoverX Corporation
If you are looking to advance compounds to the clinic, BioMAP® phenotypic profiling services will predict the behaviour of your drug candidates in patients...
product
DiscoverX PathHunter® Bioassays for Biologics
12 February 2016 | By DiscoverX Corporation
PathHunter® bioassays are cell-based assays that are highly validated, simple, and target specific to support biologics drug development...
news
Pfizer to give a keynote address on reviving covalent drug design in oncology at SMi’s 15th annual event this February
29 January 2016 | By SMi Group
SMi group reports: Doug Johnson, Research Fellow at Pfizer will be giving a keynote address on Day 1 at the SMi’s 15th annual Advances and Progress in Drug Design conference...
news
Registration has now opened for Oxford Global’s 17th Annual Drug Discovery Leaders Summit
13 January 2016 | By Oxford Global
Oxford Global Conferences are proud to present the successful 17th Annual Drug Discovery Leaders Summit and co-located 4th Annual Discovery Chemistry & Drug Design Congress taking place on the 13th & 14th June in Berlin...
product
Molecular Devices SpectraMax i3x® Multi-Mode Microplate Reader
23 December 2015 | By Molecular Devices
The SpectraMax i3x Microplate Reader from Molecular Devices evolves with your future research needs and offers an unlimited breadth of applications...
product
Molecular Devices ImageXpress® Micro Confocal High-Content Imaging System
23 December 2015 | By Molecular Devices
Run 3D cellular assays with confocal results – at a speed you’d only expect from widefield screening, with Molecular Devices’ new confocal HCS system...
whitepaper
App note: High-throughput imaging assays using zebrafish
In this application note you will find out how zebrafish screening assays and high content imaging can be used to investigate human disease models...
whitepaper
App note: Characterizing neurotoxin modulation of Nav1.5 channels
In this application note, you will learn how you can evaluate ion channel modulation by neurotoxins in a high-throughput setting...
whitepaper
Poster: Verification of Monoclonality for Cell Line Development
In this poster you will discover a fluorescent method to rapidly identify monoclonal CHO-S cells...
